For this Briefing, we asked Prof. Ellen Heitzer and Georgios Vlachos from the Institute of Human Genetics, Medical University of Graz to share their experience in working with homologous recombination deficiency (HRD) testing. Join us to familiarize yourself with the concepts and approaches central to performing this type of testing and why it is important for precision oncology. Hope to see you there!
Join us on Wednesday, February 15th, 2023. 5PM CET/6PM EET
Please join the conversation and post your comments, thoughts and questions below leading up to the briefing.
See you inside. Members have full access to this document
Your North Star in the Transformation of Precision Oncology
Consider applying to access:
Already have an account?
- Comprehensive Educational Programs
- Ongoing Professional Development
- Exclusive Access to the Vessel Community
You’ve successfully subscribed to Vessel
Welcome back! You’ve successfully signed in.
Great! You’ve successfully signed up.
Success! Your email is updated.
Your link has expired
Success! Check your email for magic link to sign-in.